A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna is advancing vaccine trials in the Democratic Republic of the Congo.Wed 19:27
  • Getty Images provided the image source for an article involving Moderna.Mon 10:11
• Merck →

  public company in Indonesia

  • Merck forged a strategic alliance with R-Pharm on November 1, 2026.Mon 06:38
  • AstraZeneca formed a partnership with Daiichi Sankyo regarding Enhertu, and also established a profit-sharing deal with Merck for Lynparza.Sun 14:45
• Eli Lilly and Company →

  American pharmaceutical company

  • Nvidia is a top holding in VOO, which also holds Apple Inc. as a major position. Warren Buffett advises investing in S&P 500 ETFs, noting Eli Lilly as a key non-tech giant.Wed 21:56
  • Trade data and legislative control are currently influencing market sentiment and corporate operations.Wed 14:24
• Nasdaq →

  American fully electronic stock exchange

  • Nasdaq is a brand that utilizes services provided by Lumen Technologies.05:34
  • Cantor Fitzgerald restated an overweight rating for MoonLake Immunotherapeutics, which trades on Nasdaq, with data provided by MarketBeat.04:27

Related events

• Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Aug 25
• Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.Jul 7
• Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.Jun 7
• Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.Oct 23
• Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Aug 19